injectable glp-1 agonists List of approved and pending medications Comparing Ozempic, Wegovy and Other
Description
GLP-1s arent for everyone
Compare early results with Wegovy and Mounjaro.
Andrew Stokes received a grant from the Robert Wood Johnson Foundation analyze the real-word effects of this new class of appetite-suppressing therapies, as well as inequities in access to these medications.
As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy
Supports a gut environment where GLP-1 thrives*: Eriomin and Feiolix promote a healthy metabolic environment by supporting gut health and maintaining balanced oxidative stress and inflammation responses.
